Wuhan Keqian Biology Hits Day Low at CNY 14.17 Amid Price Pressure

Wuhan Keqian Biology Co., Ltd. experienced a notable decline in its stock performance today, with a decrease of 6.87% as of March 23, 2026. The stock reached an intraday low of CNY 14.17, reflecting broader market trends as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Wuhan Keqian has seen a more significant drop of 11.34%, and its performance over the last month stands at a decline of 12.32%. Year-to-date, the stock has decreased by 6.75%, contrasting sharply with the Shanghai Composite's decline of 3.92%. In terms of long-term performance, the stock has faced substantial challenges, with a three-year decline of 46.24% and a five-year drop of 60.54%. Despite these figures, the company maintains a market capitalization of CNY 7,565 million and a price-to-earnings ratio of 20.00. The firm also boasts a return on equity of 10.12% and a dividend yield of 2.65%, indicating some underlying financial stability amidst current market fluctuations.